Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2023-10-26 00:00:00 ET · period of report 2023-10-24 · accession 0001209191-23-053662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-26 | 2023-10-24 | ARQT | FHM LIFE SCIENCES VIII, L.L.C. | 10% | P - Purchase | $2.50 | +80.0K | 8.76M | +0.9% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-24 | P | A | 80,000 | $2.50 | 8,764,232 | D | — | — |